ArticleFrontiers in medicine2024
The role of artificial intelligence in disease prediction: using ensemble model to predict disease mellitus.
Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nmix: a hybrid deep learning model for precise prediction of 2'-O-methylation sites based on multi-feature fusion and ensemble learning.Briefings in bioinformatics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The traditional complications of diabetes are well known and continue to pose a considerable burden to millions of people with diabetes mellitus (DM). With the continuous accumulation of medical data and technological advances, artificial intelligence has shown great potential and advantages in the prediction, diagnosis, and treatment of DM. When DM is diagnosed, some subjective factors and diagnostic methods of doctors will have an impact on the diagnostic results, so the use of artificial intelligence for fast and effective early prediction of DM patients can provide decision-making support to doctors and give more accurate treatment services to patients in time, which is of great clinical medical significance and practical significance. In this paper, an adaptive Stacking ensemble model is proposed based on the theory of "error-ambiguity decomposition," which can adaptively select the base classifiers from the pre-selected models. The adaptive Stacking ensemble model proposed in this paper is compared with KNN, SVM, RF, LR, DT, GBDT, XGBoost, LightGBM, CatBoost, MLP and traditional Stacking ensemble models. The results showed that the adaptive Stacking ensemble model achieved the best performance in five evaluation metrics: accuracy, precision, recall, F1 value and AUC value, which were 0.7559, 0.7286, 0.8132, 0.7686 and 0.8436. The model can effectively predict DM patients and provide a reference value for the screening and diagnosis of clinical DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.